144 related articles for article (PubMed ID: 9715808)
1. Effects of antidepressant drugs on rats bred for low activity in the swim test.
West CH; Weiss JM
Pharmacol Biochem Behav; 1998 Sep; 61(1):67-79. PubMed ID: 9715808
[TBL] [Abstract][Full Text] [Related]
2. Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression.
Weiss JM; Cierpial MA; West CH
Pharmacol Biochem Behav; 1998 Sep; 61(1):49-66. PubMed ID: 9715807
[TBL] [Abstract][Full Text] [Related]
3. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test.
West CH; Weiss JM
Psychopharmacology (Berl); 2005 Oct; 182(1):9-23. PubMed ID: 16047194
[TBL] [Abstract][Full Text] [Related]
4. Motor activation by amphetamine infusion into nucleus accumbens core and shell subregions of rats differentially sensitive to dopaminergic drugs.
West CH; Boss-Williams KA; Weiss JM
Behav Brain Res; 1999 Jan; 98(1):155-65. PubMed ID: 10210531
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test.
Rénéric JP; Lucki I
Psychopharmacology (Berl); 1998 Mar; 136(2):190-7. PubMed ID: 9551776
[TBL] [Abstract][Full Text] [Related]
6. Rats selectively bred for high and low swim-test activity show differential responses to dopaminergic drugs.
West CH; Bonsall RW; Emery MS; Weiss JM
Psychopharmacology (Berl); 1999 Oct; 146(3):241-51. PubMed ID: 10541723
[TBL] [Abstract][Full Text] [Related]
7. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Cryan JF; Page ME; Lucki I
Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
Torregrossa MM; Folk JE; Rice KC; Watson SJ; Woods JH
Psychopharmacology (Berl); 2005 Nov; 183(1):31-40. PubMed ID: 16220339
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.
Duncan GE; Knapp DJ; Carson SW; Breese GR
J Pharmacol Exp Ther; 1998 May; 285(2):579-87. PubMed ID: 9580601
[TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test.
Gutman DA; Coyer MJ; Boss-Williams KA; Owens MJ; Nemeroff CB; Weiss JM
Psychoneuroendocrinology; 2008 Sep; 33(8):1093-101. PubMed ID: 18676086
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
13. The effect of chronic administration of antidepressants on the circadian pattern of corticosterone in the rat.
Gómez F; Graugés P; Martín M; Armario A
Psychopharmacology (Berl); 1998 Nov; 140(2):127-34. PubMed ID: 9860102
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ
Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791
[TBL] [Abstract][Full Text] [Related]
15. Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice.
Szopa A; Poleszak E; Wyska E; Serefko A; Wośko S; Wlaź A; Pieróg M; Wróbel A; Wlaź P
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):211-21. PubMed ID: 26614569
[TBL] [Abstract][Full Text] [Related]
16. Effect of various classes of antidepressants in behavioral paradigms of despair.
Kulkarni SK; Dhir A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1248-54. PubMed ID: 17570574
[TBL] [Abstract][Full Text] [Related]
17. Open space swimming test to index antidepressant activity.
Sun MK; Alkon DL
J Neurosci Methods; 2003 Jun; 126(1):35-40. PubMed ID: 12788500
[TBL] [Abstract][Full Text] [Related]
18. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity.
Duncan GE; Knapp DJ; Johnson KB; Breese GR
J Pharmacol Exp Ther; 1996 May; 277(2):1076-89. PubMed ID: 8627519
[TBL] [Abstract][Full Text] [Related]
19. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
